CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 32 enrolled
Drug / intervention
5% Potassium nitrate +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01115452
NCT01115452Phase 2Completed
CompareCT.gov

A Proof of Principle Study Investigating the Effects of a Potassium Nitrate Solution in Reducing Dentinal Hypersensitivity

GlaxoSmithKline·interventional·Posted May 4, 2010·Updated Jan 26, 2015

In Brief

A Phase 2 clinical trial evaluating 5% Potassium nitrate, 2.5% Potassium nitrate, and 1 other intervention for Dentine Hypersensitivity. Completed, enrolled 32 participants across 1 site.

Detailed Summary

An exploratory study investigating the direct application of potassium nitrate (KNO3) solutions of different concentrations in reducing dentine hypersensitivity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentine Hypersensitivity
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 4, 2010
Enrollment StartSep 1, 2009
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.2 years ago

Interventions

5% Potassium nitratedrug

5% potassium nitrate solution

2.5% Potassium nitratedrug

2.5% potassium nitrate solution

Sterile waterother

Sterile water